AUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Absci (ABSI), a clinical-stage biotech company advancing novel therapeutics with generative AI, today announced a ...

AI-driven scientific innovation accelerated in 2025 — fueling major progress in fields ranging from robotics to health care.

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

RAMAT GAN, Israel, Oct. 23, 2025 /PRNewswire/ -- Protai, www.protai.bio, a structural proteomics and AI-driven biotech, announced its participation in four major scientific conferences this October, ...

CAMBRIDGE, Mass., Nov. 10, 2025 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a research ...

WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical and ...